NLBS
Nutralife Biosciences Inc
Price:  
0.00 
USD
Volume:  
27,510.00
United States | Personal Products
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NLBS WACC - Weighted Average Cost of Capital

The WACC of Nutralife Biosciences Inc (NLBS) is 4.1%.

The Cost of Equity of Nutralife Biosciences Inc (NLBS) is 66.65%.
The Cost of Debt of Nutralife Biosciences Inc (NLBS) is 5.00%.

Range Selected
Cost of equity 3.20% - 130.10% 66.65%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 3.7% - 4.5% 4.1%
WACC

NLBS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta -17.96 7.73
Additional risk adjustments 82.0% 82.5%
Cost of equity 3.20% 130.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 150.03 150.03
Cost of debt 5.00% 5.00%
After-tax WACC 3.7% 4.5%
Selected WACC 4.1%

NLBS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for NLBS:

cost_of_equity (66.65%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (-17.96) + risk_adjustments (82.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.